Germline Variants Drive Myelodysplastic Syndrome in Young Adults

Greenberg P, Stone R, Al-Kali A, Barta S, Bejar R, Bennett J . Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017; 15(1):60-87. DOI: 10.6004/jnccn.2017.0007. View

Keel S, Scott A, Sanchez-Bonilla M, Ho P, Gulsuner S, Pritchard C . Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients. Haematologica. 2016; 101(11):1343-1350. PMC: 5394862. DOI: 10.3324/haematol.2016.149476. View

Churpek J, Pyrtel K, Kanchi K, Shao J, Koboldt D, Miller C . Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia. Blood. 2015; 126(22):2484-90. PMC: 4661171. DOI: 10.1182/blood-2015-04-641100. View

Guidugli L, Johnson A, Alkorta-Aranburu G, Nelakuditi V, Arndt K, Churpek J . Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes. Leukemia. 2017; 31(5):1226-1229. PMC: 5420790. DOI: 10.1038/leu.2017.28. View

Wlodarski M, Hirabayashi S, Pastor V, Stary J, Hasle H, Masetti R . Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood. 2015; 127(11):1387-97. DOI: 10.1182/blood-2015-09-669937. View

Trottier A, Druhan L, Kraft I, Lance A, Feurstein S, Helgeson M . Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies. Blood Adv. 2020; 4(20):5269-5284. PMC: 7594406. DOI: 10.1182/bloodadvances.2020002013. View

Dietz A, Orchard P, Baker K, Giller R, Savage S, Alter B . Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita. Bone Marrow Transplant. 2010; 46(1):98-104. PMC: 9341256. DOI: 10.1038/bmt.2010.65. View

Ghemlas I, Li H, Zlateska B, Klaassen R, Fernandez C, Yanofsky R . Improving diagnostic precision, care and syndrome definitions using comprehensive next-generation sequencing for the inherited bone marrow failure syndromes. J Med Genet. 2015; 52(9):575-84. DOI: 10.1136/jmedgenet-2015-103270. View

Schwartz J, Ma J, Lamprecht T, Walsh M, Wang S, Bryant V . The genomic landscape of pediatric myelodysplastic syndromes. Nat Commun. 2017; 8(1):1557. PMC: 5691144. DOI: 10.1038/s41467-017-01590-5. View

10.

Milner J, Vogel T, Forbes L, Ma C, Stray-Pedersen A, Niemela J . Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood. 2014; 125(4):591-9. PMC: 4304103. DOI: 10.1182/blood-2014-09-602763. View

11.

Sebert M, Passet M, Raimbault A, Rahme R, Raffoux E, Sicre de Fontbrune F . Germline DDX41 mutations define a significant entity within adult MDS/AML patients. Blood. 2019; 134(17):1441-1444. DOI: 10.1182/blood.2019000909. View

12.

Ma X, Does M, Raza A, Mayne S . Myelodysplastic syndromes: incidence and survival in the United States. Cancer. 2007; 109(8):1536-42. DOI: 10.1002/cncr.22570. View

13.

Vaht K, Goransson M, Carlson K, Isaksson C, Lenhoff S, Sandstedt A . Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011. Haematologica. 2017; 102(10):1683-1690. PMC: 5622852. DOI: 10.3324/haematol.2017.169862. View

14.

Ebens C, MacMillan M, Wagner J . Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations. Expert Rev Hematol. 2016; 10(1):81-97. PMC: 6089510. DOI: 10.1080/17474086.2016.1268048. View